United States: FDA Final Guidance On Mobile Medical Applications

Last Updated: November 27 2013
Article by Peter A. Blenkinsop, Reed Abrahamson and Krissa Webb

On September 23, 2013, the FDA issued a guidance ("Final Guidance") explaining how medical device regulations will be applied to medical mobile applications (MMAs).1 The Final Guidance provides mobile application manufacturers with recommendations on how to comply with the regulatory and statutory requirements governing medical devices. The Guidance indicates that the FDA intends to limit its enforcement authority to only those mobile applications that operate as medical devices and pose a significant risk to patients if they fail to function as intended.

The Final Guidance outlines three categories of mobile applications (mobile apps) generally: (1) mobile apps that are not medical devices as defined under the Federal Food, Drug, and Cosmetic Act and are therefore not subject to FDA regulation; (2) mobile apps that may meet the definition of a medical device but over which the FDA intends to exercise enforcement discretion because these applications pose a low risk to the public; and (3) mobile apps that meet the definition of a medical device and which the FDA will regulate due to the significant potential risk to patient safety.

Parties Subject to Regulation

The Final Guidance applies to mobile application manufacturers—any person or entity that manufactures MMAs in accordance with the definitions of "manufacturer" found in 21 CFR Parts 803, 806, 807, and 8202—including those who initiate specifications, design, label, or create the application. The Guidance indicates that when a developer (i.e., an entity that provides engineering, design, and development services) creates a mobile medical app in accordance with a third-party's specifications (the "author"), it is the author who is considered the "manufacturer." The Guidance states that entities exclusively involved in the distribution of mobile medical applications (e.g., Apple's "App Store") will not be considered "manufacturers." The Guidance similarly states that the FDA does not intend to regulate manufacturers or distributors of mobile platforms (e.g., smartphones and tablets) marketed for general use.

Mobile Applications Subject to Regulation

The FDA has jurisdiction to regulate "medical devices," defined as "an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory ... which is intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease."3 A mobile app intended for medical use falls under the definition of a "medical device," a determination made by evaluating labeling claims, advertising materials, and statements by manufacturers and their representatives.

The Final Guidance indicates that FDA will regulate MMAs that either (1) are intended to be used as an accessory to a regulated medical device or (2) transform a mobile platform into a regulated medical device. Specifically, the FDA will regulate three categories of mobile apps:

  1. Mobile apps that act as an extension of a medical device by connecting to the device in order to control the device or display, store, analyze, or transmit patient-specific data. For example: mobile applications that control delivery of insulin by an insulin pump or that control inflation of a blood pressure cuff, as well as apps for remote display of patient monitors or remote display of radiological images from a Picture Archiving and Communications (PACS) server. This category also includes Medical Device Data System (MDDS) apps that display, store, or transmit medical device data in their original form without controlling or altering the functions of any connected device. MMAs that fall under this category are generally subject to the regulations governing the medical device to which they operate as an extension.
  2. Mobile apps that transform a mobile platform into a medical device by using attachments, display screens, or sensors or other medical device functionalities. For example: an application that allows a mobile platform to operate as a glucose meter through an attachment to a glucose strip reader; an app that turns a smartphone into an electronic stethoscope through an attachment to an external sensor; or an app that measures EKG signals through the use of external electrodes. MMAs that fall under this category must comply with the device classification associated with the transformed platform.
  3. Mobile apps that become a regulated medical device by performing patient-specific analysis and providing patient-specific diagnosis or treatment recommendations. For example: mobile applications that use patient-specific parameters and calculate dosage or create a dosage plan for radiation therapy. The Final Guidance indicates that these types of mobile medical apps are similar to or perform the same function as those types of software devices that have been previously cleared or approved. FDA gives as examples mobile apps that perform "sophisticated analysis" or interpret data from another device. In this case, manufacturers are encouraged to contact the FDA to determine what regulatory requirements may apply.

Mobile app manufacturers should consult the Final Guidance to determine whether their mobile app is subject to regulation. When a mobile app falls within the category of regulated applications, the manufacturer should determine which device classification level applies. The Final Guidance explains how to classify an MMA and directs manufacturers to the appropriate set of regulations. Regardless of classification, however, all MMA manufacturers will be required to comply with the FDA's "General Controls" for medical devices, including regulations that cover establishment registration and device listing; pre-market safety and effectiveness investigations; labeling; pre-market clearance; adverse event reporting; and corrections and removals.

Mobile Applications Not Subject to Regulation

Certain mobile apps that meet the definition of a "medical device" will not be regulated at this time because the FDA has determined that these apps pose fewer risks to patients. This includes the following categories:

  1. Mobile apps that provide or facilitate supplemental clinical care, by coaching or prompting, to help patients manage their health in their daily environment. The Final Guidance indicates that this category includes medication reminder apps intended to improve adherence, as well as apps that coach patients with specific conditions and promote strategies for maintaining health.
  2. Mobile apps that provide patients with simple tools to organize and track their health information. These apps may allow patients to input measurements and symptoms, but they do not provide any specific recommendations nor are intended to alter a previously prescribed treatment or therapy.
  3. Mobile apps that provide easy access to information related to patients' health conditions or treatments (beyond providing an electronic "copy" of a medical reference). These apps match patient-specific inputs regarding diagnosis, treatment, allergies, and/or symptoms to clinical reference information.
  4. Mobile apps that are specifically marketed to help patients document, show, or communicate to providers potential medical conditions. This would include, for example, apps that enable an individual to use a smartphone camera to take a photo of his/her condition and transmit the information to a healthcare provider.
  5. Mobile apps that perform simple calculations routinely used in clinical practice. The underlying algorithms must be derived from and available in medical sources and texts. This would include, for example, apps for calculating Body Mass Index (BMI), mean arterial pressure, or APGAR score.
  6. Mobile apps that enable individuals to interact with personal or electronic health record systems. These apps allow patients to download and view information in their PHR or EHR.

Finally, the Final Guidance recognizes that some health-related mobile apps do not meet the definition of a medical device. These apps will not be subject to the FDA's regulations. The Guidance provides a non-exhaustive list of mobile apps that are not considered medical devices. The list includes:

  1. Mobile apps that are intended to provide access to electronic copies of medical textbooks or other reference materials.
  2. Mobile apps that are intended for health care providers to use as educational tools for medical training.
  3. Mobile apps that are intended for general patient education.
  4. Mobile apps that automate general office operations in a health care setting that are not intended for the diagnosis or treatment of disease.
  5. Mobile apps that are generic aids or general purpose products.

Manufacturers of both types of unregulated mobile apps should continue to monitor statutory and regulatory developments which may lead to future oversight. MMA developers should also remain aware of other regulations that affect mobile apps, including privacy rules enforced by the FTC and state governments, and U.S. export requirements concerning applications that use encryption. Distributors of mobile apps may contractually impose requirements as well.


The Final Guidance is good news for the health care community. The FDA's voluntary limitation of enforcement authority shows that the FDA appreciates the need for innovation and the development of applications that improve individual health habits and health care quality.

Importantly, the Final Guidance does not address either clinical decision-making support tools or electronic health records. These issues may be addressed in January 2014, when the FDA, in conjunction with the National Coordinator for Health Information Technology, releases a report describing a risk-based regulatory framework for health information technology.


1 Mobile Medical Applications: Guidance for Industry and Food and Drug Administration Staff (2013), available at http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM263366.pdf ("Guidance").

2 "Manufacturer means any person who manufactures, prepares, propagates, compounds, assembles, or processes a device by chemical, physical, biological, or other procedures. The term includes any person who:

(1) Repackages or otherwise changes the container, wrapper, or labeling of a device in furtherance of the distribution of the device from the original place of manufacture to the person who makes final delivery or sale to the ultimate user or consumer;

(2) Initiates specifications for devices that are manufactured by a second party for subsequent distribution by the person initiating the specifications; or

(3) Manufactures components or accessories which are devices that are ready to be used and are intended to be commercially distributed and are intended to be used as is, or are processed by a licensed practitioner or other qualified person to meet the needs of a particular patient." 21 CFR § 806.2.

3 21 USC § 321(h).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Krissa Webb
Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions